GNH USA

Europe — EMA

Otrivine Extra Dual Relief (Xylometazoline Hydrochloride, Ipratropium Bromide)

Xylometazoline hydrochloride, the active ingredient in Otrivine Extra Dual Relief, is a nasal decongestant presented as a solution for intranasal use.

Request sourcing

1
Pack/s

What is Xylometazoline Hydrochloride, Ipratropium Bromide?

Xylometazoline hydrochloride, the active ingredient in Otrivine Extra Dual Relief, is a nasal decongestant presented as a solution for intranasal use. It relieves nasal congestion associated with colds, sinusitis and allergic rhinitis in adults and children. Ipratropium bromide, the second active ingredient, is an anticholinergic that reduces nasal secretions. GNH USA supplies Otrivine Extra Dual Relief as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

GNH USA supplies Otrivine Extra Dual Relief as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

What is Xylometazoline Hydrochloride, Ipratropium Bromide used for?

Otrivine Extra Dual Relief combines the decongestant and anticholinergic pathways to address the following nasal conditions:

- Nasal congestion: Provides rapid relief of blocked nasal passages by vasoconstriction of the nasal mucosa. - Runny the     ....

Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.

Product details

Drug
Xylometazoline Hydrochloride, Ipratropium Bromide
Route
Nasal Use
Manufacturer
Haleon Ireland Dungarvan Limited
Origin
EU

Related products